FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1868085246> ?p ?o ?g. }

• W1868085246 endingPage "e0003889" @default.
• W1868085246 startingPage "e0003889" @default.
• W1868085246 abstract "The current in vivo models for the utility and discovery of new potential anti-leishmanial drugs targeting Cutaneous Leishmaniasis (CL) differ vastly in their immunological responses to the disease and clinical presentation of symptoms. Animal models that show similarities to the human form of CL after infection with Leishmania should be more representative as to the effect of the parasite within a human. Thus, these models are used to evaluate the efficacy of new anti-leishmanial compounds before human clinical trials. Current animal models aim to investigate (i) host-parasite interactions, (ii) pathogenesis, (iii) biochemical changes/pathways, (iv) in vivo maintenance of parasites, and (v) clinical evaluation of drug candidates. This review focuses on the trends of infection observed between Leishmania parasites, the predictability of different strains, and the determination of parasite load. These factors were used to investigate the overall effectiveness of the current animal models. The main aim was to assess the efficacy and limitations of the various CL models and their potential for drug discovery and evaluation. In conclusion, we found that the following models are the most suitable for the assessment of anti-leishmanial drugs: L. major-C57BL/6 mice (or-vervet monkey, or-rhesus monkeys), L. tropica-CsS-16 mice, L. amazonensis-CBA mice, L. braziliensis-golden hamster (or-rhesus monkey). We also provide in-depth guidance for which models are not suitable for these investigations." @default.
• W1868085246 created "2016-06-24" @default.
• W1868085246 creator A5020444064 @default.
• W1868085246 creator A5020495575 @default.
• W1868085246 creator A5064142352 @default.
• W1868085246 creator A5082693573 @default.
• W1868085246 date "2015-09-03" @default.
• W1868085246 modified "2023-10-18" @default.
• W1868085246 title "A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis" @default.
• W1868085246 cites W1546173330 @default.
• W1868085246 cites W1569560012 @default.
• W1868085246 cites W1628768065 @default.
• W1868085246 cites W1665659501 @default.
• W1868085246 cites W1963577621 @default.
• W1868085246 cites W1964050061 @default.
• W1868085246 cites W1964264884 @default.
• W1868085246 cites W1964374629 @default.
• W1868085246 cites W1964507537 @default.
• W1868085246 cites W1971052526 @default.
• W1868085246 cites W1973142062 @default.
• W1868085246 cites W1974657803 @default.
• W1868085246 cites W1975004033 @default.
• W1868085246 cites W1979482928 @default.
• W1868085246 cites W1981890026 @default.
• W1868085246 cites W1982360364 @default.
• W1868085246 cites W1982865894 @default.
• W1868085246 cites W1984069235 @default.
• W1868085246 cites W1984776625 @default.
• W1868085246 cites W1984792306 @default.
• W1868085246 cites W1987216288 @default.
• W1868085246 cites W1990184846 @default.
• W1868085246 cites W1991349511 @default.
• W1868085246 cites W1994662946 @default.
• W1868085246 cites W1994719440 @default.
• W1868085246 cites W2004163475 @default.
• W1868085246 cites W2007253465 @default.
• W1868085246 cites W2007552089 @default.
• W1868085246 cites W2018623169 @default.
• W1868085246 cites W2019035680 @default.
• W1868085246 cites W2020730875 @default.
• W1868085246 cites W2026690163 @default.
• W1868085246 cites W2027109238 @default.
• W1868085246 cites W2030143165 @default.
• W1868085246 cites W2034715846 @default.
• W1868085246 cites W2036026145 @default.
• W1868085246 cites W2040879781 @default.
• W1868085246 cites W2041511981 @default.
• W1868085246 cites W2045539935 @default.
• W1868085246 cites W2053277772 @default.
• W1868085246 cites W2053342752 @default.
• W1868085246 cites W2053805691 @default.
• W1868085246 cites W2054048924 @default.
• W1868085246 cites W2054954380 @default.
• W1868085246 cites W2060246086 @default.
• W1868085246 cites W2061653285 @default.
• W1868085246 cites W2068812830 @default.
• W1868085246 cites W2068908076 @default.
• W1868085246 cites W2071550677 @default.
• W1868085246 cites W2074106415 @default.
• W1868085246 cites W2081850521 @default.
• W1868085246 cites W2082067617 @default.
• W1868085246 cites W2086314038 @default.
• W1868085246 cites W2093988796 @default.
• W1868085246 cites W2095530340 @default.
• W1868085246 cites W2095640199 @default.
• W1868085246 cites W2099764007 @default.
• W1868085246 cites W2102828449 @default.
• W1868085246 cites W2104823023 @default.
• W1868085246 cites W2109803080 @default.
• W1868085246 cites W2112338833 @default.
• W1868085246 cites W2113811423 @default.
• W1868085246 cites W2117303758 @default.
• W1868085246 cites W2117873458 @default.
• W1868085246 cites W2122271831 @default.
• W1868085246 cites W2127151497 @default.
• W1868085246 cites W2130746097 @default.
• W1868085246 cites W2132044546 @default.
• W1868085246 cites W2139616386 @default.
• W1868085246 cites W2140906980 @default.
• W1868085246 cites W2144440730 @default.
• W1868085246 cites W2150185307 @default.
• W1868085246 cites W2156862710 @default.
• W1868085246 cites W2160542942 @default.
• W1868085246 cites W2160700506 @default.
• W1868085246 cites W2165529080 @default.
• W1868085246 cites W2166171364 @default.
• W1868085246 cites W2167617386 @default.
• W1868085246 cites W2171410982 @default.
• W1868085246 cites W2177761511 @default.
• W1868085246 cites W2205865704 @default.
• W1868085246 cites W2249460648 @default.
• W1868085246 cites W2270692836 @default.
• W1868085246 cites W2325452928 @default.
• W1868085246 cites W2331361831 @default.
• W1868085246 cites W2332232222 @default.
• W1868085246 cites W2339986720 @default.
• W1868085246 cites W2406525189 @default.
• W1868085246 cites W2408839450 @default.

• next